BF Biosciences gains DRAP's approval for brownfield expansion

MG News | September 09, 2024 at 11:49 AM GMT+05:00

0:00

September 09, 2024 (MLN): BF Biosciences Limited, a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ), has secured approval from the Drug Regulatory Authority of Pakistan (DRAP) for its brownfield expansion (Line II).

This expansion includes a pre-filled syringes line, a liquid and lyophilized line, and a product development section.

The commercial production from the pre-filled syringes line has commenced, whereas the liquid & lyophilized line is under internal validation and will start commercial production in the second quarter of FY 2024-25.

Additionally, BF Biosciences Limited has launched Sematide (Semaglutide) in a pre-filled syringe.

Sematide is the first Glucagon-Like Peptide 1 (GLP1) receptor agonist approved for local manufacture in Pakistan, offering a convenient solution for diabetes management.

The pre-filled syringe eliminates dosing errors and is easy to use by the patients.

Sematide is being manufactured at the new state-of-the-art European prefilled syringes line of BF Biosciences Limited.

Copyright Mettis Link News

Related News

Name	Price/Vol	%Chg/NChg
KSE100	165,517.51 456.73M	-0.18% -293.50
ALLSHR	98,448.76 882.77M	-0.24% -241.23
KSE30	50,169.05 247.97M	-0.30% -151.34
KMI30	241,192.40 220.37M	-0.66% -1611.26
KMIALLSHR	64,572.12 452.80M	-0.40% -256.88
BKTi	45,529.23 74.60M	-0.15% -69.56
OGTi	34,306.12 16.75M	-2.12% -741.41

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	72,080.00	72,800.00 70,650.00	605.00 0.85%
BRENT CRUDE	96.32	99.50 94.22	1.57 1.66%
RICHARDS BAY COAL MONTHLY	105.00	105.00 105.00	-0.40 -0.38%
ROTTERDAM COAL MONTHLY	105.70	110.00 105.70	-1.95 -1.81%
USD RBD PALM OLEIN	1,175.00	1,175.00 1,175.00	0.00 0.00%
CRUDE OIL - WTI	98.02	102.70 95.25	3.61 3.82%
SUGAR #11 WORLD	13.95	14.30 13.90	-0.28 -1.97%